Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory PapillomatosisInterventions: Drug: Bevacizumab; Drug: Cidofovir; Other: PlaceboSponsor: Centro de Investigación en. Enfermedades Infecciosas, MexicoRecruiting - verified September 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials